RBI
ARCT icon

Raiffeisen Bank International’s Arcturus Therapeutics ARCT Stock Holding History

Raiffeisen Bank International’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,321
Closed -$21.2K – 818
2025
Q2 		$17.2K Hold
1,321
– – ﹤0.01% 535
2025
Q1 		$14K Hold
1,321
– – ﹤0.01% 549
2024
Q4 		$22.2K Buy
+1,321
New +$24.9K ﹤0.01% 540

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raiffeisen Bank International's ARCT Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 1,321 shares — an estimated $21.2K sold.

Raiffeisen Bank International first reported a position in ARCT in Q4 2024 and held it in 3 quarters. The position peaked at $22.2K in Q4 2024. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 1,321 Arcturus Therapeutics shares in Q3 2025, an estimated $21.2K.
  • Raiffeisen Bank International first reported a position in Arcturus Therapeutics in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Arcturus Therapeutics position peaked at $22.2K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.